Certican 0.25mg Tablet
Everolimus (0.25mg)
by Novartis India Ltd
strip of 10 tablets
About this medicine
Certican 0.25mg Tablet is used for the prevention of organ rejection in transplant patients. It regulates the body’s immune response, so the body can accept the new organ. It is also used in combination with other medicines to treat cancers of breast, pancreas, lungs, and kidney. Certican 0.25mg Tablet must be taken in a dose and duration as per the prescription. It can be taken with or without food but make sure to take it at about the same time every day. An overdose of this medicine may have serious side effects on the body. The common side effects of this medicine include infection, fever, cough, fatigue, diarrhea, and upper respiratory infection. If any of the side effects persist or bother you, consult the doctor immediately. Inform the doctor immediately if you experience any allergic reactions (rash, shortness of breath, coughing, swelling, etc.). Always seek medical advice if you have increased thirst or increased frequency of urination, suffer from shortness of breath, cough or fever, or need to receive any vaccination after taking this medication. Before taking this medicine, it is important to consult your doctor if you have any ongoing medication for any underlying disease. Pregnant and breastfeeding women must inform the doctor prior to the initiation of this treatment. During the treatment, your doctor may advise you for some laboratory tests to know the effects of the medicine in the body. It may affect male or female fertility, so consult the doctor if you are planning to have a child.
Uses
- Prevention of organ rejection in transplant patients
Benefits
In prevention of organ rejection in transplant patients
Certican 0.25mg Tablet is used with other medications to prevent organ transplant rejection. Rejection usually happens due to attack by the immune system of the person receiving the transplanted organ on the transplant itself, in people who are receiving any organ transplants, like kidney, liver, heart etc. This medicine reduces the activity of a person's own immune system and prevents any such rejection.
How it works
Certican 0.25mg Tablet suppresses the activity of body's immune system and prevents rejection of the transplanted organ.
How to use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Certican 0.25mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Common side effects
- Infection
- Fever
- Cough
- Fatigue
- Diarrhea
- Upper respiratory tract infection
Safety advice
- AlcoholCONSULT YOUR DOCTOR
- It is not known whether it is safe to consume alcohol with Certican 0.25mg Tablet. Please consult your doctor.
- PregnancyCONSULT YOUR DOCTOR
- Certican 0.25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
- Breast feedingCONSULT YOUR DOCTOR
- Certican 0.25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
- DrivingUNSAFE
- Certican 0.25mg Tablet may cause side effects which could affect your ability to drive. As fatigue is a common side effect with Certican 0.25mg Tablet and this may affect your ability to drive
- KidneySAFE IF PRESCRIBED
- Certican 0.25mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Certican 0.25mg Tablet is recommended.
- LiverCAUTION
- Certican 0.25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Certican 0.25mg Tablet may be needed. Please consult your doctor. Use of Certican 0.25mg Tablet is not recommended in patients with severe liver disease.
Quick facts
- Chemical Class
- Macrolide Lactams
- Habit Forming
- No
- Therapeutic Class
- Anti neoplastics
Frequently asked questions
Is any monitoring required while taking Certican 0.25mg Tablet?
Regular monitoring is required while you are on Certican 0.25mg Tablet. The doctor will advise blood tests to see the counts of red blood cells, white blood cells, and platelets since the counts may decrease during treatment with Certican 0.25mg Tablet. Also, blood tests will be required to check your kidney function, liver function, blood glucose levels, and cholesterol levels.
What should I avoid while taking Certican 0.25mg Tablet?
You should avoid grapefruit or grapefruit juice while taking Certican 0.25mg Tablet. This is because taking them together may increase the levels of Certican 0.25mg Tablet in your blood to harmful levels. Avoid the use of live vaccinations and any possible contact with individuals who have received live vaccinations.
What is the most important information I need to know about Certican 0.25mg Tablet?
Certican 0.25mg Tablet can cause serious side effects which include severe allergic reactions, angioedema, and kidney failure which can be severe and can lead to death. It is possible that you may develop an infection or problems related to lung such as breathing problems.
Is Certican 0.25mg Tablet a chemotherapy?
Certican 0.25mg Tablet is an anticancer medicine. It belongs to kinase inhibitor class of medicines. It works by reducing the blood supply to the tumor, which slows down the growth and spread of cancer cells.
How is Certican 0.25mg Tablet administered?
Usually, Certican 0.25mg Tablet is taken once or twice daily. The medicine should always either be taken with food or always be taken without food. Certican 0.25mg Tablet should be swallowed whole with water and should not be crushed or chewed.
How long can you take Certican 0.25mg Tablet?
There is no definite duration of treatment with Certican 0.25mg Tablet. Certican 0.25mg Tablet is continued till clinical benefit is seen or unacceptable toxicity or side effects occur.
How will I know that Certican 0.25mg Tablet is shrinking my brain tumor?
The effect of Certican 0.25mg Tablet in shrinking the size of tumor can only be checked by getting regular brain scans. It should be done as advised by your doctor and your treatment plan.
Is Certican 0.25mg Tablet cytotoxic?
Yes, Certican 0.25mg Tablet is cytotoxic against human cancer cells of breast, stomach, prostate, and kidneys (renal cell carcinoma).
Product details
- Manufacturer
- Novartis India Ltd
- Salt composition
- Everolimus (0.25mg)
- Pack
- strip of 10 tablets
- Dosage form
- Tablet
- Storage
- Store below 30°C
Same salt, other brands
Therapeutically equivalent. Ask your doctor or our pharmacist before substituting.
The content above is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a registered medical practitioner before starting, stopping or changing any medicine.